Egetis Therapeutics AB (publ) (STO:EGTX)

Sweden · Delayed Price · Currency is SEK

7.24

+0.01 (0.14%)

Aug 13, 2026, 5:29 PM CET

Egetis Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,366	2,110	2,515	1,633	1,524	1,016
Market Cap Growth	69.75%	-16.09%	54.03%	7.15%	49.92%	-10.17%
Enterprise Value	3,299	1,971	2,278	1,438	1,396	872.26
Last Close Price	7.24	5.34	7.00	5.58	7.10	6.16

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	22.61	5.66	5.66	5.66	5.66
PS Ratio	53.35	33.82	54.55	28.34	67.42	26.60
PB Ratio	13.54	6.23	5.10	2.99	3.01	1.93
P/TBV Ratio	-	-	25.63	10.63	14.37	9.57

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	52.28	31.58	49.41	24.96	61.76	22.83

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.15	0.13	0.17	0.19	0	0
Net Debt / Equity Ratio	-0.29	-0.41	-0.48	-0.36	-0.25	-0.27
Net Debt / EBITDA Ratio	0.20	0.41	0.72	0.60	0.65	1.36
Net Debt / FCF Ratio	0.27	0.52	1.04	0.70	0.74	1.11
Asset Turnover	0.11	0.09	0.06	0.09	0.04	0.06
Inventory Turnover	26.44	30.30	13.65	16.92	9.69	4.12
Quick Ratio	0.65	1.01	1.83	3.27	2.79	3.85
Current Ratio	0.69	1.05	1.86	3.33	2.98	3.90
Return on Equity (ROE)	-86.67%	-82.18%	-66.04%	-62.16%	-37.51%	-18.05%
Return on Assets (ROA)	-62.53%	-47.44%	-42.40%	-49.15%	-35.05%	-16.43%
Return on Invested Capital (ROIC)	-195.75%	-149.07%	-108.44%	-89.03%	-52.03%	-29.12%
Return on Capital Employed (ROCE)	-105.38%	-68.92%	-52.94%	-55.62%	-38.03%	-17.96%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-16.70%	-20.10%	-19.57%	-33.86%	-7.97%	-166.96%
Total Shareholder Return	-16.70%	-20.10%	-19.57%	-33.86%	-7.97%	-166.96%